Faith Davies, MD, shares insights from the IMS 2024 session on high-risk disease, highlighting the debut of a unified high-risk definition. This new framework incorporates 17p deletions, mutations,…
Multiple myeloma is a significant yet lesser-known type of blood cancer. In this Mayo Clinic Health System video, discover key insights about multiple myeloma, including its symptoms, prevalence,…
Recent Videos in Multiple Myeloma Content Hub Page 4
In a study of 16,331 patients in the California Cancer Registry, 5.7% developed a second primary malignancy more than 1 year after diagnosis. The 10-year cumulative incidence of…
In a study designed to investigate the biological relevance of PARP1 in multiple myeloma (MM), data revealed a significant correlation between increased PARP1 mRNA expression and poor prognosis…
